Hedy L. Kindler, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Targeted Therapy
The University of Chicago Medicine Duchossois Center for Advanced Medicine
Currently practicing at the The University of Chicago Medicine Center as the director of the mesothelioma program, Dr. Kindler is one of the top experts in the country dealing with this type of cancer. She completed her medical school in 1989 at the State University of New York in Buffalo and her residency at the University of California Medical Center. After completing her fellowship at the Memorial Sloan-Kettering Cancer Center, Dr. Hedy Kindler started focusing on research and clinical trials of newly developed treatment methods for the above mentioned mesothelioma. These studies earned her current position, and a very well respected reputation in the medical community.
Yale University
Education
State University of New York at Buffalo - 1989
Medical School
UCLA Medical Center
Residency
Memorial Sloan-Kettering Cancer Center
Fellowship
American Board of Internal Medicine - Oncology
Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly.
Williams, T.,Duraid, H.,Watson, S.,Durkin, A.,Todd, K.,Kindler, H. L.,Vigneswaran, W. T.; Ann. Thorac. Surg.
See more >>Radiologic-pathologic correlation of mesothelioma tumor volume. Armato,
S. G.,Li, P.,Husain, A. N.,Straus, C.,Khanwalkar, A.,Kindler, H. L.,Vigneswaran, W. T.; Lung Cancer.
See more >>Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
Lamont, E. B.,Schilsky, R. L.,He, Y.,Muss, H.,Cohen, H. J.,Hurria, A.,Meilleur, A.,Kindler, H. L.,Venook, A.,Lilenbaum, R.,Niell, H.,Goldberg, R. M
See more >>American Association for Cancer Research
American Society of Clinical Oncology
International Association for the Study of Lung Cancer
International Mesothelioma Interest Group
Mesothelioma Applied Research Foundation